Doxazosin how supplied storage and handling

Doxazosin
Doxazosin®, Cardura® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings
Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Doxazosin
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]

HOW SUPPLIED

Doxazosin Tablets, USP are available as white to off-white tablets for oral administration. Each tablet contains doxazosin mesylate equivalent to 1 mg, 2 mg, 4 mg or 8 mg of the active constituent, doxazosin.

Doxazosin Tablets, USP are available as 1 mg (white to off-white, round, scored tablets, imprinted “APO” on one side and “093” with a partial bisect on the other side), 2 mg (white to off-white, capsule shaped, scored tablets, imprinted “APO” on one side and “094” with a partial bisect on the other side), 4 mg (white to off-white, capsule shaped, scored tablets, imprinted “APO” on one side and “095” with a partial bisect on the other side) and 8 mg (white to off-white, capsule shaped, scored tablets, imprinted “APO” on one side and “096” with a partial bisect on the other side).

Bottles of 100:

1 mg (NDC 60505-0093-0)

2 mg (NDC 60505-0094-0)

4 mg (NDC 60505-0095-0)

8 mg (NDC 60505-0096-0)

Bottles of 1,000:

1 mg (NDC 60505-0093-1)

2 mg (NDC 60505-0094-1)

4 mg (NDC 60505-0095-1)

8 mg (NDC 60505-0096-1)

Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].

Dispense in a tight, light-resistant container [see USP].

APOTEX INC.

DOXAZOSIN TABLETS, USP

1 mg, 2 mg, 4 mg and 8 mg